Literature DB >> 15350964

Nitric oxide synthase and intermittent hypoxia-induced spatial learning deficits in the rat.

Richard C Li1, Barry W Row, Leila Kheirandish, Kenneth R Brittian, Evelyne Gozal, Shang Z Guo, Leroy R Sachleben, David Gozal.   

Abstract

Intermittent hypoxia (IH) during sleep induces significant neurobehavioral deficits in the rat. Since nitric oxide (NO) has been implicated in ischemia-reperfusion-related pathophysiological consequences, the temporal effects of IH (alternating 21% and 10% O(2) every 90 s) and sustained hypoxia (SH; 10% O(2)) during sleep for up to 14 days on the induction of nitric oxide synthase (NOS) isoforms in the brain were examined in the cortex of Sprague-Dawley rats. No significant changes of endothelial NOS (eNOS) and neuronal NOS (nNOS) occurred over time with either IH or SH. Similarly, inducible NOS (iNOS) was not affected by SH. However, increased expression and activity of iNOS were observed on days 1 and 3 of IH (P < 0.01 vs. control; n = 12/group) and were followed by a return to basal levels on days 7 and 14. Furthermore, IH-mediated neurobehavioral deficits in the water maze were significantly attenuated in iNOS knockout mice. We conclude that IH is associated with a time-dependent induction of iNOS and that the increased expression of iNOS may play a critical role in the early pathophysiological events leading to IH-mediated neurobehavioral deficits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350964     DOI: 10.1016/j.nbd.2004.05.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  49 in total

Review 1.  Hypoxia. 3. Hypoxia and neurotransmitter synthesis.

Authors:  Ganesh K Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

2.  Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.

Authors:  Richard C Li; Bodduluri Haribabu; Steven P Mathis; Jinkwan Kim; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

3.  Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.

Authors:  R C Li; S Z Guo; M Raccurt; E Moudilou; G Morel; K R Brittian; D Gozal
Journal:  Neuroscience       Date:  2011-08-23       Impact factor: 3.590

Review 4.  The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.

Authors:  Andreia G Andrade; Omonigho M Bubu; Andrew W Varga; Ricardo S Osorio
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Systemic inflammation impairs respiratory chemoreflexes and plasticity.

Authors:  A G Huxtable; S Vinit; J A Windelborn; S M Crader; C H Guenther; J J Watters; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2011-06-25       Impact factor: 1.931

Review 6.  Inflammatory pathways in children with insufficient or disordered sleep.

Authors:  Jinkwan Kim; Fahed Hakim; Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2011-05-05       Impact factor: 1.931

Review 7.  The polymorphic and contradictory aspects of intermittent hypoxia.

Authors:  Isaac Almendros; Yang Wang; David Gozal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-16       Impact factor: 5.464

Review 8.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

9.  Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity.

Authors:  D Nair; V Ramesh; D Gozal
Journal:  Neuroscience       Date:  2012-10-11       Impact factor: 3.590

10.  A pilot study of sleep, cognition, and respiration under 4 weeks of intermittent nocturnal hypoxia in adult humans.

Authors:  Matthew D Weiss; Renaud Tamisier; Judith Boucher; Mekkin Lynch; Geoffrey Gilmartin; J Woodrow Weiss; Robert Joseph Thomas
Journal:  Sleep Med       Date:  2009-03-17       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.